is an early-stage biotech company at the forefront of drug discovery and development. We are designing small molecules that regulate mental states and restore critical biological processes. Our aim is to develop meta-programming drugs that provide immediate relief while fostering long-term behavioral transformations critical for health and wellbeing.

We are building an AI-powered in vivo phenotypic screening platform to accelerate drug discovery and repurposing through a target-agnostic approach. Pisces™ uses computer vision and machine learning techniques to identify the behavioral fingerprint of each compound and predict its therapeutic applications.

Join us as we work to revolutionize the treatment of body and mind.